Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Print
Meng Qian, PhD
Director, Statistician
Daiichi Sankyo, Inc.
Poster(s):
042: Pharmacokinetics & Exposure-safety Analyses Across Tumor Types for Ifinatamab Deruxtecan (I-DXd) in the First-in-Human Study IDeate-Pantumor01 (DS7300-A-J101)
Sunday, September 8, 2024
5:00 PM – 7:00 PM
ET
092: Concentration-QTc Interim Analysis of I-DXd in Subjects With Advanced Solid Tumors from Study IDeate-Pantumor01 (DS7300-A-J101)
Monday, September 9, 2024
5:00 PM – 7:00 PM
ET
